RECOVERY · Spray
BPC Spray.
Oral BPC-157 for gut and systemic healing
How it works
Class & mechanism.
Class
Synthetic Peptide — Oral/Sublingual Delivery
Mechanism
BPC-157 Spray delivers the same 15-amino acid peptide sequence as injectable BPC-157, but exploits a unique property that distinguishes it from nearly every other therapeutic peptide: native stability in human gastric juice. While most peptides are rapidly degraded by stomach acid and proteolytic enzymes, BPC-157 was originally isolated from gastric juice — meaning it is natively resistant to GI degradation. Administered as an oral spray, BPC-157 achieves direct mucosal contact with the buccal cavity, oesophagus, and stomach lining, enabling concentrated local healing activity throughout the GI tract. Some systemic absorption occurs, supporting broader tissue repair via circulation, though local GI effects are more pronounced than with injectable routes.
Did you know
BPC-157 was discovered because scientists were puzzled by the stomach's ability to constantly regenerate its own lining despite bathing in acid strong enough to dissolve metal — they found this peptide living inside that acid, protecting and rebuilding tissue, and realised they could extract and use it therapeutically.
Benefits
What it does.
Direct gastric and intestinal mucosal repair — heals ulcers, counters NSAID-induced damage, and restores gut barrier integrity through direct contact with the affected tissue
Leaky gut syndrome management — supports tight junction repair and intestinal permeability restoration, addressing the root cause rather than masking symptoms
Needle-free delivery for GI-primary conditions — oral spray is the ideal route when the gut lining itself is the target, providing concentrated local exposure before any systemic distribution
Gut-brain axis support — BPC-157 modulates the enteric nervous system and neurotransmitter balance (serotonin, dopamine) via the gut, offering indirect CNS benefits through the GI route
Systemic tissue support — residual systemic absorption provides anti-inflammatory and tissue-repair signalling throughout the body, though at lower systemic levels than subcutaneous injection
The science
Peer-reviewed findings.
Research supporting this compound's mechanisms and safety profile.
BPC-157 is uniquely stable in human gastric juice — it was originally isolated from it — making it one of the only therapeutic peptides that retains biological activity after oral ingestion, a property confirmed across multiple studies by Sikiric et al. and validated in IBD clinical trials
SOURCE · PMC7096228 — Stable Gastric Pentadecapeptide BPC 157; Sikiric P et al., multiple publications
Oral and intragastric administration of BPC-157 demonstrates protective effects against alcohol-induced gastric mucosal damage, NSAID-induced ulceration, and inflammatory bowel conditions — with the same equipotent dosing range as injectable routes for GI-specific indications
SOURCE · Frontiers in Pharmacology 2021 (PMC): Stable Gastric Pentadecapeptide BPC 157 and Wound Healing; Becejac et al. 2018, J Physiol Pharmacol
BPC-157 has demonstrated ability to recover brain-gut axis integrity in preclinical models (PMC10224484), suggesting that oral administration targeting the GI tract produces secondary neurological benefits via the enteric-CNS connection — a pathway injectable routes are less likely to specifically engage
SOURCE · PMC10224484 — Stable Gastric Pentadecapeptide BPC 157 May Recover Brain–Gut Axis
Protocol
How to use it.
Dosing
500 mcg–1 mg daily via oral spray. Typically administered as 4–8 sprays per dose (depending on concentration), held briefly under the tongue or against the buccal mucosa before swallowing for maximum mucosal contact. For acute GI conditions, twice-daily dosing (morning and evening, away from food) is common. For systemic support via oral route, once daily is standard.
Cycle
4–8 weeks for acute digestive issues (gastric ulcers, NSAID damage, acute gut inflammation). 8–12 weeks for chronic conditions (leaky gut, IBD, chronic GI inflammation). Rest period of 4 weeks between cycles for chronic use. Oral route is preferred over injection specifically when GI conditions are the primary target.
Contraindications
When to skip it.
Same theoretical concerns as injectable BPC-157 apply (angiogenesis promotion, theoretical cancer risk). Not FDA-approved. Oral bioavailability for systemic effects is lower than subcutaneous injection — not the preferred route for musculoskeletal or neurological indications. Product quality varies significantly by supplier — purity and peptide stability are paramount. Not a replacement for injectable BPC-157 when systemic musculoskeletal healing is the goal.
Always cleared with your concierge before protocol start.
Pricing
What it costs.
Indicative range for BPC Spray, sourced from vetted US and EU dispensing suppliers. Concierge confirms the exact figure once your match is locked.
Indicative range (USD)
Sourced through vetted dispensing partners in the United States and European Union. Concierge confirms the exact figure once your match is locked.
- 0199% purity verified, third-party tested
- 02Nasal spray, ready to use
- 03Concierge supplier match included with every protocol
See BPC Spray pricing — and your supplier match.
Pricing is unlocked once we know who you are. Take the 3-minute quiz and we'll match you to a US or EU dispensary based on your location and protocol fit.
- Live USD price range
- US & EU supplier shortlist
- Concierge sign-off on dosing
Indicative price range: $119–$179 USD